Out-licensing

A complementary liquid presentation associated with the symptomatic relief of dry cough.

Dosage form: Oral liquid Strength: 6 mg/ml Therapeutic area: Respiratory system Key indication: Symptomatic relief of dry cough Product class: Cough suppressant Dossier st...

An oral solid presentation associated with the symptomatic relief of dry cough.

Dosage form: Tablet Strength: 60 mg Therapeutic area: Respiratory system Key indication: Symptomatic relief of dry cough Product class: Cough suppressant Dossier status: Available ...

A broad-strength capsule opportunity associated with attention deficit hyperactivity disorder.

Dosage form: Hard capsule Strengths: 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg Therapeutic area: Nervous system Key indication: Attention deficit hyperactivity disorde...

A six-strength ACE-inhibitor opportunity undergoing reformulation.

Dosage form: Film-coated tablet Strengths: 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg Therapeutic area: Cardiovascular Key indication: Hypertension Product class: ACE inhibitor Expected d...

A four-strength angiotensin II receptor blocker opportunity undergoing reformulation.

Dosage form: Film-coated tablet Strengths: 12.5 mg, 25 mg, 50 mg and 100 mg Therapeutic area: Cardiovascular Key indication: Hypertension Product class: Angiotensin II re...

A prolonged-release oral product associated with circadian-rhythm sleep disorders.

Dosage form: Prolonged-release tablet Strength: 2 mg Therapeutic area: Nervous system Key indication: Circadian-rhythm sleep disorders Product class: Hypnotic and sedative a...

An oral pipeline opportunity associated with the treatment of breast cancer.

Dosage form: Film-coated tablet Strengths: 75 mg, 100 mg and 125 mg Therapeutic area: Antineoplastic and immunomodulating agents Key indication: Breast cancer Product class:...

A broad-strength central nervous system reformulation opportunity.

Dosage form: Hard capsule Strengths: 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg Therapeutic area: Nervous system Key indication: Neuropathic pain Product class: Analgesic Exp...

A multi-strength hematology pipeline opportunity associated with myelofibrosis.

Dosage form: Tablet Strengths: 5 mg, 10 mg, 15 mg, 20 mg and 25 mg Therapeutic area: Antineoplastic and immunomodulating agents Key indication: Myelofibrosis Product clas...

A targeted-oncology pipeline opportunity associated with metastatic melanoma.

Dosage form: Film-coated tablet Strengths: 0.5 mg and 2 mg Therapeutic area: Antineoplastic and immunomodulating agents Key indication: Metastatic melanoma Product class: P...

A four-strength anxiolytic tablet portfolio undergoing reformulation.

Dosage form: Tablet Strengths: 0.25 mg, 0.5 mg, 1 mg and 2 mg Therapeutic area: Nervous system Key indication: Anxiety Product class: Anxiolytic Dossier status: Available Estimated CPP timi...

A three-component fixed-dose combination opportunity for partners seeking to expand their cardiovascular portfolio.

Dosage form: Film-coated tablet Strengths: 5 mg/1.25 mg/5 mg, 5 mg/2.5 mg/10 mg, 10 mg/1.25 mg/5 mg and 10 mg/2.5 mg/10 mg Therapeutic area: Cardiovas...

A short explainer video introducing Medis now, our online customer portal which gives our customers access to valuable information, insights and ordering capabilities 24/7.

A short video introduction to Medis, where you can find out all the basic information about the company and how it operates and in which markets.